Tuesday, July 1, 2025 7/1/2025

Mechanisms controlling Ca2+ dyshomeostasis in MH susceptible mice

Award Number: R01AR068897
ORGANIZATION: NATIONAL INSTITUTE OF ARTHRITIS & MUSCULOSKELETAL & SKIN DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 11/01/2016
PERIOD OF PERFORMANCE END DATE: 08/31/2022

Group Awards By:

View Award Description

Mechanisms controlling Ca2+ dyshomeostasis in MH susceptible mice - DESCRIPTION (provided by applicant): The long-term goal of this research is to define the mechanisms responsible for the malignant hyperthermia syndrome. We have previously shown that a universal feature of RyR1 MH mutations is an increased resting myoplasmic free Ca2+ concentration ([Ca2+]i) and more recently that they are associated with an increased resting Na+ concentration ([Na+]i). We have also shown that sarcoplasmic reticulum (SR) leak is a factor in controlling myoplasmic Ca2+ concentration at rest working in concert with sarcolemmal channels, pumps and exchangers. Furthermore, because the amount of Ca2+ in internal stores is limited compared to the extracellular pool, after MH is triggered these same sarcolemmal channels, pumps and exchangers and perhaps others must be involved in the maintenance of the MH syndrome. Because of the observed increase in [Na+]i in MH muscles, TRPCs are the most likely candidates. Our immediate objectives are to use two mouse models that we have created, RyR1-R163C a mouse model of human MH, and CSQ1 null mice, which have an MH like phenotype, to study how mutations that alter intracellular Ca2+ homeostasis cause a fulminant MH response when exposed to volatile anesthetics. These models will allow us to test a unified general hypothesis applicable to any and all MH mutations regardless of the location of the mutation: MH is caused by conformational changes in RyR1 as a result of a mutation, or by conformational changes in RyR1 induced indirectly by a mutation in CaV1.1 or another protein closely associated with RyR1 (as demonstrated by an MH like phenotype in Casq1 null mice). A transformative concept to be investigated here is that a defect in signaling among Ca2+ release unit proteins leading to increased RyR1 leak is a common convergent pathway leading to all MH susceptibility. Hypothesis 1: MH susceptibility is the result of a conformational change in RyR1 caused either by a RyR1 mutation, or induced indirectly by mutations in other proteins closely associated with RyR1 which results in increased RyR1 SR Ca2+ leak and sarcolemmal Na+ and Ca2+ entry. Specific Aim 1. To determine the filling state of the SR and rate of SR Ca2+ leak in MH muscle fibers. Specific Aim 2. To determine the role of TRPCs in causing abnormalities in sarcolemmal Na+ and Ca2+ entry RyR1-R163C and CSQ1 null muscles and then to determine if skeletal muscle specific over-expression of a dominant negative non-conducting TRPC6 channel can modify RyR1-R163C's MH phenotype. Hypothesis 2: In addition to blocking RyR1 SR Ca2+ release, dantrolene abrogates the MH phenotype by modulating RyR1 SR Ca2+ leak and sarcolemmal Na+ and Ca2+ entry. Specific Aim 3. To determine the mechanisms by which dantrolene diminishes aberrant Ca2+ signaling. Successful completion of these specific Aims will provide a more comprehensive understanding of MH.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2023 ( Subtotal = -$8,051 )
2023	2020	UNIVERSITY OF LEEDS	WOODHOUSE LANE	LEEDS				GBR	Arthritis, Musculoskeletal and Skin Diseases Research	000	6	5/2/2023	NON-COMPETING CONTINUATION	-$8,051
														Subtotal = -$8,051

Issue Date FY: 2021 ( Subtotal = $0 )
2021	2020	UNIVERSITY OF LEEDS	WOODHOUSE LANE	LEEDS	WEST YORKSHIRE			GBR	Arthritis, Musculoskeletal and Skin Diseases Research	001	6	7/19/2021	NON-COMPETING CONTINUATION	$0
2021	2019	UNIVERSITY OF LEEDS	WOODHOUSE LANE	LEEDS	WEST YORKSHIRE			GBR	Arthritis, Musculoskeletal and Skin Diseases Research	000	5	11/4/2020	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2020 ( Subtotal = $237,600 )
2020	2020	UNIVERSITY OF LEEDS	WOODHOUSE LANE	LEEDS	WEST YORKSHIRE	LS2 9JT		GBR	Arthritis, Musculoskeletal and Skin Diseases Research	000	6	9/1/2020	NON-COMPETING CONTINUATION	$237,600
														Subtotal = $237,600

Issue Date FY: 2019 ( Subtotal = $237,600 )
2019	2019	UNIVERSITY OF LEEDS	WOODHOUSE LANE	LEEDS	WEST YORKSHIRE	LS2 9JT		GBR	Arthritis, Musculoskeletal and Skin Diseases Research	000	5	9/10/2019	NON-COMPETING CONTINUATION	$237,600
														Subtotal = $237,600

Issue Date FY: 2018 ( Subtotal = $130,075 )
2018	2018	UNIVERSITY OF LEEDS	WOODHOUSE LANE	LEEDS	WEST YORKSHIRE	LS2 9JT		GBR	Arthritis, Musculoskeletal and Skin Diseases Research	000	4	9/12/2018	NON-COMPETING CONTINUATION	$130,075
														Subtotal = $130,075

Issue Date FY: 2017 ( Subtotal = $237,600 )
2017	2017	UNIVERSITY OF LEEDS	WOODHOUSE LANE	LEEDS	WEST YORKSHIRE	LS2 9JT		GBR	Arthritis, Musculoskeletal and Skin Diseases Research	004	3	8/23/2017	NON-COMPETING CONTINUATION	$237,600
2017	2016	UNIVERSITY OF LEEDS	WOODHOUSE LANE	LEEDS	WEST YORKSHIRE	LS2 9JT		GBR	Arthritis, Musculoskeletal and Skin Diseases Research	002	2	5/1/2017	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	-$345,125
2017	2016	UNIVERSITY OF CALIFORNIA, DAVIS	1850 RESEARCH PARK DR, STE 300	DAVIS	CA	95618	YOLO	USA	Arthritis, Musculoskeletal and Skin Diseases Research	000	1	10/25/2016	NEW	-$345,125
2017	2016	UNIVERSITY OF LEEDS	WOODHOUSE LANE	LEEDS	WEST YORKSHIRE	LS2 9JT		GBR	Arthritis, Musculoskeletal and Skin Diseases Research	003	2	5/3/2017	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$345,125
2017	2016	THE UNIVERSITY OF LEEDS	WOODHOUSE LA	LEEDS	WEST YORKSHIRE	LS2 9JT		GBR	Arthritis, Musculoskeletal and Skin Diseases Research	001	2	11/4/2016	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$345,125
														Subtotal = $237,600

Issue Date FY: 2016 ( Subtotal = $345,125 )
2016	2016	UNIVERSITY OF CALIFORNIA	1850 RESEARCH PARK DRIVE	DAVIS	CA	95618	YOLO	USA	Arthritis, Musculoskeletal and Skin Diseases Research	000	1	2/17/2016	NEW	$345,125
														Subtotal = $345,125

Grand Total All Awards = $1,179,949

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Mechanisms controlling Ca2+ dyshomeostasis in MH susceptible mice

Award Number: R01AR068897

ORGANIZATION: NATIONAL INSTITUTE OF ARTHRITIS & MUSCULOSKELETAL & SKIN DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 11/01/2016

PERIOD OF PERFORMANCE END DATE: 08/31/2022

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer